| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2026 |
| Trial ID | NCT03765177 |
| Disease | Chronic Lymphocytic Leukemia | Acute Lymphoblastic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CLIC-1901 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies |
| Year | 2018 |
| Country | Canada |
| Company sponsor | Ottawa Hospital Research Institute |
| Other ID(s) | CLIC-01 Study |
| Cohort 1 | |||||||||||
|
|||||||||||